Ticker: OCUP

Company: REXAHN PHARMACEUTICALS, INC.

Person: Cam Gallagher, director

Transaction date: Dec. 29, 2025

Reporting date: Dec. 31, 2025

Average share price: 1.6431137055837564

Bought 197000.0 shares for 323693.4